MDxHealth
About:
MDxHealth is a molecular diagnostics company that develops epigenetic tests for cancer assessment and personalized treatment of patients.
Website: http://mdxhealth.com
Twitter/X: MDxHealth
Top Investors: EASME - EU Executive Agency for SMEs, Idinvest Partners, Kreos Capital, MVM Life Science Partners, Innovatus Capital Partners
Description:
MDxHealth is a molecular diagnostics company that develops and commercializes advanced epigenetic tests for cancer assessment and the personalized treatment of patients.
Total Funding Amount:
$169M
Estimated Revenue Range:
$50M to $100M
Headquarters Location:
Irvine, California, United States
Founded Date:
2003-01-01
Contact Email:
info(AT)mdxhealth.com
Founders:
Number of Employees:
51-100
Last Funding Date:
2024-09-25
IPO Status:
Public
Industries:
© 2025 bioDAO.ai